Carrie Kitko, MD, moderated a session on new and emerging treatment options for chronic graft-versus-host disease.

Keith Sullivan, MD, and others discussed progress with transplantation and cell therapy for autoimmune diseases.

Cell and gene therapy pricing is driven by market forces, explained David Rind, MD, MSc, and other experts.

Honorees Fernando Duarte, PhD, Sergio Giralt, MD, Joseph H. Antin, MD, and Robert Zeiser, MD, share some of the ideas that helped propel their careers.

This session on the manipulation of T-cell signaling includes fundamental discoveries and cutting-edge clinical advances, says Caitlin Zebley, MD, PhD.

Causal inference techniques are becoming increasingly important as researchers make use of large registry databases, explains Kwang Woo Ahn, PhD.